Gobivaz
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Gobivaz, covering 2025-11-20 to 2026-07-21. Get the full timeline:
Most recent: EMA Authorised: Gobivaz (golimumab) — Advanz Pharma Limited
2 regulatory and trial events tracked for Gobivaz, covering 2025-11-20 to 2026-07-21. Get the full timeline:
Most recent: EMA Authorised: Gobivaz (golimumab) — Advanz Pharma Limited